De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): Characteristics and prognosis

Authors:

Abstract
No abstract available
Funding Information
  • Daiichi-Sankyo
  • Roche
  • Eisai
  • Meso Scale Diagnostics
  • Pfizer
  • AstraZeneca
  • Les Laboratories Pierre Fabre

This publication has 17 references indexed in Scilit: